Menu
GWAS Study

A genome-wide association study identifies two new risk loci for Graves' disease.

Chu X, Pan CM, Zhao SX et al.

21841780 PubMed ID
GWAS Study Type
10462 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CX
Chu X
PC
Pan CM
ZS
Zhao SX
LJ
Liang J
GG
Gao GQ
ZX
Zhang XM
YG
Yuan GY
LC
Li CG
XL
Xue LQ
SM
Shen M
LW
Liu W
XF
Xie F
YS
Yang SY
WH
Wang HF
SJ
Shi JY
SW
Sun WW
DW
Du WH
ZC
Zuo CL
SJ
Shi JX
LB
Liu BL
GC
Guo CC
ZM
Zhan M
GZ
Gu ZH
ZX
Zhang XN
SF
Sun F
WZ
Wang ZQ
SZ
Song ZY
ZC
Zou CY
SW
Sun WH
GT
Guo T
CH
Cao HM
MJ
Ma JH
HB
Han B
LP
Li P
JH
Jiang H
HQ
Huang QH
LL
Liang L
LL
Liu LB
CG
Chen G
SQ
Su Q
PY
Peng YD
ZJ
Zhao JJ
NG
Ning G
CZ
Chen Z
CJ
Chen JL
CS
Chen SJ
HW
Huang W
SH
Song HD
Chapter II

Abstract

Summary of the research findings

Graves' disease is a common autoimmune disorder characterized by thyroid stimulating hormone receptor autoantibodies (TRAb) and hyperthyroidism. To investigate the genetic architecture of Graves' disease, we conducted a genome-wide association study in 1,536 individuals with Graves' disease (cases) and 1,516 controls. We further evaluated a group of associated SNPs in a second set of 3,994 cases and 3,510 controls. We confirmed four previously reported loci (in the major histocompatibility complex, TSHR, CTLA4 and FCRL3) and identified two new susceptibility loci (the RNASET2-FGFR1OP-CCR6 region at 6q27 (P(combined) = 6.85 × 10(-10) for rs9355610) and an intergenic region at 4p14 (P(combined) = 1.08 × 10(-13) for rs6832151)). These newly associated SNPs were correlated with the expression levels of RNASET2 at 6q27, of CHRNA9 and of a previously uncharacterized gene at 4p14, respectively. Moreover, we identified strong associations of TSHR and major histocompatibility complex class II variants with persistently TRAb-positive Graves' disease.

1,468 Chinese ancestry cases, 1,490 Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

10462
Total Participants
GWAS
Study Type
Yes
Replicated
3,994 Chinese ancestry cases, 3,510 Chinese ancestry controls
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.